Dysregulation of C/EBPα by mutant Huntingtin causes the urea cycle deficiency in Huntington's disease
The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
Huntington's disease (HD) is an autosomal dominant neurodegenerative disease caused by a CAG trinucleotide expansion in the Huntingtin (Htt) gene. Using two mouse models of HD, we demonstrate that the urea cycle deficiency characterized by hyperammonemia, high blood citrulline and suppression of urea cycle enzymes is a prominent feature of HD. The resultant ammonia toxicity might exacerbate the neurological deficits of HD. Suppression of C/EBPalpha, a crucial transcription factor for the transcription of urea cycle enzymes, appears to mediate the urea cycle deficiency in HD. We found that in the presence of mutant Htt, C/EBPalpha loses its ability to interact with an important cofactor (CREB-binding protein). Moreover, mutant Htt recruited C/EBPalpha into aggregates, as well as suppressed expression of the C/EBPalpha gene. Consumption of protein-restricted diets not only led to the restoration of C/EBPalpha's activity, and repair of the urea cycle deficiency and hyperammonemia, but also ameliorated the formation of Htt aggregates, the motor deterioration, the suppression of striatal brain-derived neurotrophic factor and the normalization of three protein chaperones (Hsp27, Hsp70 and Hsp90). Treatments aimed at repairing the urea cycle deficiency may provide a new strategy for dealing with HD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, deficits in toxin clearance in aged livers increase the concentrations of circulating toxic substances, especially citrulline and ammonia, which may accelerate the onset of HD.232”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [232]
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055
Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1362 · Cited by 2,347
Loss of Huntingtin-Mediated BDNF Gene Transcription in Huntington's Disease
Zuccato, C., Ciammola, A., Rigamonti, D., Leavitt, B. R., Goffredo, D., Conti, L., MacDonald, M. E., Friedlander, R. M., Silani, V., Hayden, M. R., et al. (2001) · Science · doi:10.1126/science.1059581 · Cited by 1,123
Steffan, J. S., Kazantsev, A., Spasic-Boskovic, O., Greenwald, M., Zhu, Y.-Z., Gohler, H., Wanker, E. E., Bates, G. P., Housman, D. E., & Thompson, L. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100110097 · Cited by 1,062
Wu, Z., Rosen, E. D., Brun, R., Hauser, S., Adelmant, G., Troy, A. E., McKeon, C., Darlington, G. J., & Spiegelman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80306-8 · Cited by 1,015
Impaired Energy Homeostasis in C/EBPα Knockout Mice
Wang, N.-D., Finegold, M. J., Bradley, A., Ou, C. N., Abdelsayed, S. V., Wilde, M. D., Taylor, L. R., Wilson, D. R., & Darlington, G. J. (1995) · Science · doi:10.1126/science.7652557 · Cited by 929
Differential loss of striatal projection neurons in Huntington disease.
Reiner, A., Albin, R. L., Anderson, K. D., D'Amato, C. J., Penney, J. B., & Young, A. B. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5733 · Cited by 839
Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease
Tanaka, M., Machida, Y., Niu, S., Ikeda, T., Jana, N. R., Doi, H., Kurosawa, M., Nekooki, M., & Nukina, N. (2004) · Nature Medicine · doi:10.1038/nm985 · Cited by 782
The U.S.–Venezuela Collaborative Research Project*, & Wexler, N. S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308679101 · Cited by 761
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
Luthi-Carter, R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1259 · Cited by 720
Neurological abnormalities in a knock-in mouse model of Huntington's disease
Lin, C.-H. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.2.137 · Cited by 592
Almost all about citrulline in mammals
Curis, E., Nicolis, I., Moinard, C., Osowska, S., Zerrouk, N., Bénazeth, S., & Cynober, L. (2005) · Amino Acids · doi:10.1007/s00726-005-0235-4 · Cited by 571
Wyttenbach, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.9.1137 · Cited by 494
Martindale, D., Hackam, A., Wieczorek, A., Ellerby, L., Wellington, C., McCutcheon, K., Singaraja, R., Kazemi-Esfarjani, P., Devon, R., Kim, S. U., et al. (1998) · Nature Genetics · doi:10.1038/ng0298-150 · Cited by 485
Jana, N. R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.13.2009 · Cited by 432
Duan, W., Guo, Z., Jiang, H., Ware, M., Li, X.-J., & Mattson, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0536856100 · Cited by 428
Christy, R. J., Kaestner, K. H., Geiman, D. E., & Lane, M. D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2593 · Cited by 385
Karpuj, M. V., Becher, M. W., Springer, J. E., Chabas, D., Youssef, S., Pedotti, R., Mitchell, D., & Steinman, L. (2002) · Nature Medicine · doi:10.1038/nm0202-143 · Cited by 379
Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway
Yamamoto, A., Cremona, M. L., & Rothman, J. E. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200510065 · Cited by 360
Hay, D. G. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh144 · Cited by 327
Iwata, A., Christianson, J. C., Bucci, M., Ellerby, L. M., Nukina, N., Forno, L. S., & Kopito, R. R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505801102 · Cited by 318
Tryptophan metabolism and oxidative stress in patients with Huntington's disease
Stoy, N., Mackay, G. M., Forrest, C. M., Christofides, J., Egerton, M., Stone, T. W., & Darlington, L. G. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03070.x · Cited by 310
Formation of Polyglutamine Inclusions in Non-CNS Tissue
Sathasivam, K., Hobbs, C., Turmaine, M., Mangiarini, L., Mahal, A., Bertaux, F., Wanker, E. E., Doherty, P., Davies, S. W., & Bates, G. P. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.5.813 · Cited by 289
Identification and Characterization of the Potential Promoter Regions of 1031 Kinds of Human Genes
Suzuki, Y., Tsunoda, T., Sese, J., Taira, H., Mizushima-Sugano, J., Hata, H., Ota, T., Isogai, T., Tanaka, T., Nakamura, Y., et al. (2001) · Genome Research · doi:10.1101/gr.164001 · Cited by 261
CREB-binding protein and p300: molecular integrators of hematopoietic transcription
Blobel, G. A. (2000) · Blood · doi:10.1182/blood.v95.3.745.003k05_745_755 · Cited by 260
Borrell-Pages, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27607 · Cited by 236
[24] Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates
Wanker, E. E., Scherzinger, E., Heiser, V., Sittler, A., Eickhoff, H., & Lehrach, H. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)09026-6 · Cited by 233
Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes.
Hurlbert, M. S., Zhou, W., Wasmeier, C., Kaddis, F. G., Hutton, J. C., & Freed, C. R. (1999) · Diabetes · doi:10.2337/diabetes.48.3.649 · Cited by 218
Superoxide Production and Antioxidant Enzymes in Ammonia Intoxication in Rats
Kosenko, E., Kaminsky, M., Kaminsky, A., Valencia, M., Lee, L., Hermenegildo, C., & Felipo, V. (1997) · Free Radical Research · doi:10.3109/10715769709097867 · Cited by 217
Luthi-Carter, R. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.17.1927 · Cited by 211
Acute ammonia toxicity is mediated by the NMDA type of glutamate receptors
Marcaida, G., Felipo, V., Hermenegildo, C., Miñana, M.-D., & Grisolia, S. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80404-5 · Cited by 197
Identification and Characterization of the Potential Promoter Regions of 1031 Kinds of Human GenesPreprint
Suzuki, Y., Tsunoda, T., Sese, J., et al. (2001) · Genome Research · doi:10.1101/gr.gr-1640r · Cited by 188
Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles
Underwood, B. R., Broadhurst, D., Dunn, W. B., Ellis, D. I., Michell, A. W., Vacher, C., Mosedale, D. E., Kell, D. B., Barker, R. A., Grainger, D. J., et al. (2006) · Brain · doi:10.1093/brain/awl027 · Cited by 183
CGS21680 attenuates symptoms of Huntington's disease in a transgenic mouse model
Chou, S., Lee, Y., Chen, H., Chiang, M., Lai, H., Chang, H., Wu, Y., Sun, C., Chien, C., Lin, Y., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03029.x · Cited by 173
Self-citationINCREASED FREQUENCY OF DIABETES MELLITUS IN PATIENTS WITH HUNTINGTON'S CHOREA
Podolsky, S., Leopold, N., & Sax, D. (1972) · The Lancet · doi:10.1016/s0140-6736(72)91092-6 · Cited by 172
Effect of ammonium ions on synaptic transmission in the mammalian central nervous system
SZERB, J., & BUTTERWORTH, R. (1992) · Progress in Neurobiology · doi:10.1016/0301-0082(92)90008-3 · Cited by 165
Selective Neuronal Degeneration in Huntington's Disease
(2006) · Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)75002-5 · Cited by 163
Huntington’s disease: A randomized, controlled trial using the NMDA-antagonist amantadine
Verhagen Metman, L., Morris, M. J., Farmer, C., Gillespie, M., Mosby, K., Wuu, J., & Chase, T. N. (2002) · Neurology · doi:10.1212/wnl.59.5.694 · Cited by 162
Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila
Agrawal, N., Pallos, J., Slepko, N., Apostol, B. L., Bodai, L., Chang, L.-W., Chiang, A.-S., Thompson, L. M., & Marsh, J. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500055102 · Cited by 162
Bergamini, E., Cavallini, G., Donati, A., & Gori, Z. (2003) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(03)00048-9 · Cited by 155
NMDA Receptor antagonists prevent acute ammonia toxicity in mice
Hermenegildo, C., Marcaida, G., Montoliu, C., Grisolía, S., Miñana, M., & Felipo, V. (1996) · Neurochemical Research · doi:10.1007/bf02532401 · Cited by 151
Bialostosky, K., Wright, J. D., Kennedy‐Stephenson, J., McDowell, M., & Johnson, C. L. (2002) · PubMed · Cited by 145
Jackson, M. J., Beaudet, A. L., & O’Brien, W. E. (1986) · Annual Review of Genetics · doi:10.1146/annurev.ge.20.120186.002243 · Cited by 132
Lai, H.-L., Yang, T.-H., Messing, R. O., Ching, Y.-H., Lin, S.-C., & Chern, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.8.4970 · Cited by 129
Self-citationSchiefer, J., Landwehrmeyer, G. B., Lüesse, H., Sprünken, A., Puls, C., Milkereit, A., Milkereit, E., & Kosinski, C. M. (2002) · Movement Disorders · doi:10.1002/mds.10229 · Cited by 117
Wu, J.-Y., Kao, H.-J., Li, S.-C., Stevens, R., Hillman, S., Millington, D., & Chen, Y.-T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19574 · Cited by 104
Self-citationTesta, A., Donati, G., Yan, P., Romani, F., Huang, T. H.-M., Viganò, M. A., & Mantovani, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414039200 · Cited by 91
Chiang, M.-C., Lee, Y.-C., Huang, C.-L., & Chern, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413279200 · Cited by 89
Self-citationArgininosuccinate Synthetase is Reversibly Inactivated by S-Nitrosylation in Vitro and in Vivo
Hao, G., Xie, L., & Gross, S. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404866200 · Cited by 84
Mitochondrial dysfunction in acute hyperammonemia
Felipo, V., & Butterworth, R. F. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00119-x · Cited by 80
The nutritional management of urea cycle disorders
Leonard, J. V. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.111835 · Cited by 77
Kimura, T., Christoffels, V. M., Chowdhury, S., Iwase, K., Matsuzaki, H., Mori, M., Lamers, W. H., Darlington, G., & Takiguchi, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27505 · Cited by 73
Öllinger, K., & Roberg, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23707 · Cited by 65
Lee, Y., Chien, C., Sun, C., Huang, C., Huang, N., Chiang, M., Lai, H., Lin, Y., Chou, S., Wang, C. L., et al. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02907.x · Cited by 54
Self-citationEndo, F., Matsuura, T., Yanagita, K., & Matsuda, I. (2004) · Journal of Nutrition · doi:10.1093/jn/134.6.1605s · Cited by 54
Huntington's disease and its association with psychopathology
De Marchi, N. (2000) · Harvard Review of Psychiatry · doi:10.1093/hrp/7.5.278 · Cited by 47
Induction of hsp 72/73 by herbimycin A, an inhibitor of transformation by tyrosine kinase oncogenes
Murakami, Y., Uehara, Y., Yamamoto, C., Fukazawa, H., & Mizuno, S. (1991) · Experimental Cell Research · doi:10.1016/0014-4827(91)90382-5 · Cited by 46
Robinson, M. B., Hopkins, K. J., Batshaw, M. L., McLaughlin, B., Heyes, M. P., & Oster‐Granite, M. L. (1995) · Developmental Brain Research · doi:10.1016/0165-3806(96)83484-5 · Cited by 43
CAG mutation effect on rate of progression in Huntington's disease
Squitieri, F., Cannella, M., & Simonelli, M. (2002) · Neurological Sciences · doi:10.1007/s100720200092 · Cited by 42
Kavanaugh, B., Beesley, J., Itoh, T., Itoh, A., Grinspan, J. B., & Pleasure, D. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000615)60:6<725::aid-jnr4>3.0.co;2-v · Cited by 41
Recurrent Psychosis Associated with Liver Disease and Elevated Blood Ammonia
HAVENS, L. L., & Child, C. G. (1955) · New England Journal of Medicine · doi:10.1056/nejm195505052521804 · Cited by 38
G�rseth, M., Sonnewald, U., White, L. R., R�d, M., Zwart, J., Nygaard, �., & Aasly, J. O. (2000) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20000615)60:6<779::aid-jnr10>3.0.co;2-m · Cited by 38
Liu, F.-C., Wu, G.-C., Hsieh, S., Lai, H., Wang, H.-F., Wang, T., & Chern, Y. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01098-9 · Cited by 35
Self-citationRecent advances in Huntingtonʼs disease
Gutekunst, C., Norflus, F., & Hersch, S. M. (2000) · Current Opinion in Neurology · doi:10.1097/00019052-200008000-00013 · Cited by 35
Mechanisms for Intragenic Complementation at the Human Argininosuccinate Lyase Locus
Yu, B., Thompson, G. D., Yip, P., Howell, P. L., & Davidson, A. R. (2001) · Biochemistry · doi:10.1021/bi011526e · Cited by 27
A pilot study of neonatal screening by electrospray ionization tandem mass spectrometry in Taiwan.
Lin, W., Wu, J., Lai, C., Tsai, F., Tsai, C., Lin, S.-P., & Niu, D. (2001) · PubMed · Cited by 20
Self-citationMatsubasa, T., Takiguchi, M., Matsuda, I., & Mori, M. (1994) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a124626 · Cited by 18
Cited by
Manganese Is Essential for Neuronal Health
Horning, K. J., Caito, S. W., Tipps, K. G., Bowman, A. B., & Aschner, M. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071714-034419 · Cited by 602
“For example, many critical Mn-dependent enzymes of the brain show diminished levels of activity in HD patients and other models of HD (36, 44, 45).”
BackgroundTherapeutic potential of mood stabilizers lithium and valproic acid:Beyond bipolar disorder
Chiu, C.-T., Wang, Z., Hunsberger, J. G., & Chuang, D.-M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005512 · Cited by 404
Role of manganese in neurodegenerative diseases
Bowman, A. B., Kwakye, G. F., Herrero Hernández, E., & Aschner, M. (2011) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2011.08.144 · Cited by 395
Beyond the brain: widespread pathology in Huntington's disease
van der Burg, J. M., Björkqvist, M., & Brundin, P. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70178-4 · Cited by 363
Hsiao, H.-Y., Chen, Y.-C., Chen, H.-M., Tu, P.-H., & Chern, Y. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt036 · Cited by 239
Self-citation
Metadata
- Authors
- Chiang, M.-C., Chen, H.-M., Lee, Y.-H., Chang, H.-H., Wu, Y.-C., Soong, B.-W., Chen, C.-M., Wu, Y.-R., Liu, C.-S., Niu, D.-M., Wu, J.-Y., Chen, Y.-T., & Chern, Y.
- Affiliations
- Institute of Biomedical Sciences, Academia Sinica (TW)
- Chang Gung Memorial Hospital (TW)
- Taipei Veterans General Hospital (TW)
- Changhua Christian Hospital (TW)
- Corresponding author
- Chern, Yijuang
- ORCID
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-01-09
- Volume
- 16
- Issue
- 5
- Pages
- 483-498
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2149248612
- Cited by
- 95
- References
- 68
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 4 · 2023: 6 · 2022: 5 · 2021: 6 · 2020: 4 · 2019: 4 · 2018: 5 · 2017: 7 · 2016: 2 · 2015: 9 · 2014: 4 · 2013: 5 · 2012: 5
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- Huntington's disease, mutant huntingtin, C/EBPα, hyperammonemia, citrulline, CREB-binding protein, protein aggregation, low-protein diet, brain-derived neurotrophic factor, striatum, HSP27, HSP70, HSP90, transcriptional regulation, ammonia toxicity
- MeSH terms
- Huntingtin Protein, Animals, Citrulline, Diet, Female, Humans, Huntington Disease, Liver, Male, Middle Aged, Motor Activity, Nerve Tissue Proteins, Nuclear Proteins, Promoter Regions, Genetic, Protein Binding, Urea, Down-Regulation, Disease Progression, Brain-Derived Neurotrophic Factor, Protein Structure, Quaternary, CCAAT-Enhancer-Binding Protein-alpha, Mutant Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.